Aybintio

E2042592 UNEXPLORED

Aybintio is a biosimilar version of the cancer drug bevacizumab, developed for the treatment of various solid tumors.

Try in SPARQL Jump to: Surface forms Referenced by

All labels observed (1)

Label Occurrences
Aybintio canonical 1

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

Samsung Bioepis → hasProduct → Aybintio ⓘ